Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Influenza: prevention and treatment].

R Snacken1

  • 1Institut Scientifique de Santé Publique, Section Virologie, Bruxelles.

Revue Medicale De Bruxelles
|October 30, 2001
PubMed
Summary

Influenza prevention through inactivated vaccines is key for at-risk groups. New evidence suggests lowering the vaccination age to 45 and highlights the importance of immunizing healthcare workers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2015
Same author

New developments of influenza surveillance in Europe.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2015
Same author

Influenza season 2012-2013 in Europe: moderate intensity, mixed (sub)types.

Epidemiology and infection·2014
Same author

Influenza season 2013/14 has started in Europe with influenza A(H1)pdm09 virus being the most prevalent subtype.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2014
Same author

Influenza-related deaths--available methods for estimating numbers and detecting patterns for seasonal and pandemic influenza in Europe.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2012
Same author

Overrepresentation of influenza A(H1N1)pdm09 virus among severe influenza cases in the 2011/12 season in four European countries.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2012

Area of Science:

  • Virology
  • Epidemiology
  • Immunology

Context:

  • Influenza remains a significant public health concern, necessitating effective prevention and treatment strategies.
  • Current vaccination guidelines for influenza have limitations, particularly regarding age cut-offs for at-risk populations.

Purpose:

  • To review current strategies for influenza prevention and treatment.
  • To discuss the potential benefits of lowering the vaccination age and expanding healthcare worker immunization.
  • To evaluate the role of neuraminidase inhibitors in chemoprophylaxis and treatment.

Summary:

  • Inactivated influenza vaccines are crucial for preventing severe illness in at-risk individuals.
  • Lowering the vaccination age to 45 years is proposed based on mortality data.
  • Immunizing healthcare workers is vital for patient safety and reducing absenteeism.
  • Intranasal live attenuated influenza vaccines show promise, especially for children.
  • Neuraminidase inhibitors may be effective for outbreak control and influenza treatment, potentially reducing antibiotic misuse.

Impact:

  • Optimizing influenza vaccination strategies can mitigate the impact of epidemics.
  • Enhanced immunization of healthcare workers can improve patient outcomes and healthcare system resilience.
  • Further research into neuraminidase inhibitors could lead to improved influenza management and reduced antibiotic resistance.

Related Experiment Videos